INAB

IN8BIO, INC.

Healthcare · Biotechnology

$214.02 sample

+1.07 (+0.50%) 1D

Market cap

$222.7B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-07

Alerts

8

Price$214.02 -1.31% 3M daily closessample

228.74212.55

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: Chief Executive Officer
Oct 02INSInsider sell: General Counsel
Sep 25INSInsider sell: Chief Financial Officer
Sep 21INSInsider sell: Chief Executive Officer
Sep 16INSInsider sell: EVP, Operations
Sep 10INSInsider sell: EVP, Operations
Sep 07SECDEF 14A filed
Sep 02INSInsider sell: 10% owner

Sign up to see the real INAB record →

Company facts

SEC EDGAR registration

Name: IN8BIO, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +49sample, -100 to +100
Reporting currency: USD

Who is positioning in INAB

sample

Insiders: 20 insider transactions over 90 days, net selling, $584.0M
Congress: 4 members traded over 90 days
Institutions · 13F: 18 funds hold $1.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$5.5B +13.2% y/y

Q4 2024Q3 2026

Inventory$3.5B +13.9% y/y

Q4 2024Q3 2026

Accounts receivable$2.5B +11.7% y/y

Q4 2024Q3 2026

Total debt$6.8B +14.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $98.8B -5.9% 3M
Sample peer B: $31.9B -8.9% 3M
Sample peer C: $103.5B +4.3% 3M
Sample peer D: $202.5B -9.0% 3M
Sample peer E: $78.3B -9.9% 3M